Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.93% -0.02% 822.55M 885592.0
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.17% 179.0% -335.26M Upgrade

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Equity
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2018
2019
2020
2021
2022
2023
2024
YTD
-57.60%
75.51%
74.66%
-64.15%
-80.36%
-13.42%
-26.02%
79.44%
-4.38%
31.49%
18.40%
28.71%
-18.11%
26.29%
25.02%
17.84%
-22.64%
66.16%
-20.34%
75.37%
-32.10%
22.17%
55.71%
14.00%
-39.89%
71.89%
-7.83%
27.87%
-62.48%
26.20%
7.21%
14.59%
-23.89%
75.26%
-17.16%
65.58%
-32.38%
32.76%
28.47%
23.91%
-48.47%
28.96%
-7.82%
-58.55%
-71.96%
-53.17%
36.00%
62.40%
As of December 04, 2025.

Asset Allocation

As of October 31, 2025.
Type % Net
Cash -45.90%
Stock 67.45%
Bond 20.83%
Convertible 0.00%
Preferred 0.00%
Other 57.62%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks daily investment results of 300% of the performance of the S&P Biotechnology Select Industry Index. The Fund creates long positions by investing at least 80% of its assets in the securities that comprise the Index and/or financial instruments that provide leveraged and unleveraged exposure to the Index.
General
Security Type Exchange-Traded Fund
Broad Asset Class Miscellaneous
Broad Category Equity
Global Peer Group Alternative Equity Leveraged
Peer Group Equity Leverage Funds
Global Macro Alternative Equity
US Macro Large-Cap Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Equity Leverage Funds
Fund Owner Firm Name Direxion
Broad Asset Class Benchmark Index
^SPXTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders